CLINICAL_TRIALS
trial_result
· 2011-01-10
Clinical Trial Update: Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 study evaluating the combination of exenatide and insulin glargine in adults with Type 2 Diabetes Mellitus; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2011-01-10